First insights into microbial changes within an Inflammatory Bowel Disease Family Cohort study Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Epidemiology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany; Popgen biobank, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Epidemiology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Division of Gastroenterology, Department of Medicine, Mater Dei Hospital, Msida, Malta.
Institute of Biotechnology, Faculty Environment and Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany; Medipan/GA Generic Assays GmbH, Blankenfelde-Mahlow, Germany.
Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Epidemiology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany; Popgen biobank, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Medical Informatics and Statistics, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany; Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Epidemiology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany; Popgen biobank, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.
Show others and affiliations
2025 (English) In: Gut microbes, ISSN 1949-0976, E-ISSN 1949-0984, Vol. 17, no 1, article id 2559119Article in journal (Refereed) Published
Abstract [en]
The prospective Kiel Inflammatory Bowel Disease (IBD) Family Cohort Study (KINDRED cohort) was initiated in 2013 to systematically and extensively collect data and biosamples from index IBD patients and their relatives, a population at high risk for IBD development. Regular follow-ups were conducted to collect updated health and lifestyle information, to obtain new biosamples, and to capture the incidence of IBD during development. By combining microbial data collected at successive time points with extensive anthropometric, medical, nutritional, and social information, this study aimed to characterize the factors influencing the microbiota in health and disease via detailed ecological analyses. Using a microbial dysbiosis metric based on the German KINDRED cohort, we identified strong and generalizable gradients within and across different external IBD cohorts for validation. These community gradients correspond strongly with IBD pathologies, physiological manifestations of inflammation (e.g. Bristol stool score, ASCA IgA, ASCA IgG), and genetic risk for IBD. Anthropometric and medical factors influencing fecal transit time strongly modify bacterial communities. Various Enterobacteriaceae (e.g. Klebsiella sp.) and opportunistic Clostridia pathogens (e.g. C. XIVa clostridioforme), characterize in combination with ectopically colonizing oral taxa (e.g. Veillonella sp. Cand. Saccharibacteria sp. Fusobacterium nucleatum) the distinct and chaotic IBD-specific communities. Weak community and physiological changes are further traceable in a small number of individuals, who developed IBD in the study's runtime. Our findings demonstrate broad-scale ecological patterns which indicate drastic state transitions of communities in IBD patients. These patterns appear to be universal across cohorts and influence physiological signs of inflammation, display increased resilience, but show only limited heritability/intrafamily transmission.
Place, publisher, year, edition, pages Taylor & Francis, 2025. Vol. 17, no 1, article id 2559119
Keywords [en]
16S, Family Cohort, IBD, dysbiosis, inflammatory bowel disease, microbiota, oralization
National Category
Gastroenterology and Hepatology
Identifiers URN: urn:nbn:se:oru:diva-124197 DOI: 10.1080/19490976.2025.2559119 ISI: 001588042400001 PubMedID: 41047557 Scopus ID: 2-s2.0-105017833043 OAI: oai:DiVA.org:oru-124197 DiVA, id: diva2:2004032
Funder German Research Foundation (DFG)
Note Funding Agencies:
The KINDRED cohort received funding from the German Research Foundation (DFG) through Excellence Clusters “Inflammation at interfaces” (EXC 306) and “Precision Medicine in Inflammation” (PMI; EXC 2167), as well as from the Research Unit miTarget [FOR 5042]. This study was also supported by a grant from the German Ministry of Education and Research [01ZX1606A].
2025-10-062025-10-062026-01-23 Bibliographically approved